Molecular Diagnostics
POC Molecular TB Test Could Enable Clinicians to Begin Appropriate Treatment Immediately
A new molecular TB testing system currently under development aims to provide highly accurate results at a low price at the point of care, enabling clinicians to immediately commence appropriate treatment and patient management to maximize health outcomes and minimize further spread of infection. More...15 Dec 2022
New Digital Platform Technology Aims to Disrupt 50-Year-Old PCR Testing for Similar-Symptom Pathogens
A disruptive new diagnostic testing platform that uses electronic nanosensors to detect the genetic material of numerous pathogens could reshape the future of diagnostic testing. More...14 Dec 2022
Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes
Lupus erythematosus (LE) is a severe autoimmune disease characterized by the presence of many abnormal immune cells and a large number of autoantibodies and immune complexes, all of which lead to damage to multiple organs, such as the skin, kidney, and brain. More...12 Dec 2022
PCR-Based CRC Early Detection Stool Test Fills Important Gap Between FIT and Colonoscopy
A simple-to-administer test detects colorectal cancer with a sensitivity and specificity nearly as high as the invasive colonoscopy. The test utilizes proprietary methods to analyze cell DNA for specific tumor markers combined with the fecal immunochemical tests. More...12 Dec 2022
Early-Pregnancy Urine Test Could Predict Preeclampsia
Researchers have discovered biomarkers in the blood and urine of women with preeclampsia that could lead to a low-cost test to predict the condition months before a pregnant woman shows symptoms. Predictive testing would enable better pregnancy monitoring and the development of more effective treatments. More...12 Dec 2022
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Gold Member
Collection and Transport System
PurSafe Plus®
Clinical Chemistry System
P780
In Other News
Portable qPCR Platform Enables Faster, Better, Low-Cost Near-Patient Molecular Diagnosis
Long COVID Etiologies Found in Acute Infection Blood Samples
POCT Immunoassay Reader Provides Quantitative Analysis of Test Kits for More Accurate Diagnosis
World’s First Rapid Saliva-Based Pregnancy Test Eliminates Need for Blood and Urine Samples
Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants
Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes
New Blood Test Detects ‘Toxic’ Protein Years Before Alzheimer’s Symptoms Emerge
Biomarkers Predict Lyme Disease Post-Treatment Prognosis
Low Cost, Highly Sensitive Blood Test for Cancer Makes Regular Monitoring Affordable
New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process
Method Enables Targeted Profiling of Human Extrachromosomal DNA
ctDNA-Based MRD Test to Detect As Few As One Mutant Molecule in a Million DNA Molecules
Study Identifies Optimal Blood Tests for Detection and Treatment of Early Stage Alzheimer’s
Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage
Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer
New Serological Test Could Search for Viral Triggers of Diseases
Blood-Based NIPS Test Improves Access to Genetic Testing
Two Tau Variants Distinguish Corticobasal Degeneration from Other Tauopathies
First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours
Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer
Altered Ratios of p53 Isoforms Predict Response of Breast Tumors to Chemotherapy
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.